Internationale Kapitalanlagegesellschaft mbH, Düsseldorf
HSBC INKA is one of the leading investment administration companies (KVG) in Germany. Since the launch of apo Medical Opportunities Institutional, HSBC INKA has been our partner.
Further information at www.inka-kag.de
Hauck & Aufhäuser Fund Services S. A. und Hauck & Aufhäuser Fund Platforms S.A. (H&A) (formerly Oppenheim)
Since 2000, H&A has been our partner for fund management, administration and reporting for the MEDICAL BioHealth. Hauck & Aufhäuser Fund Platforms S.A. in Luxembourg provides the custodian bank services. These include custody of assets, investment limit checks, evaluation and fund pricing, the processing of all transactions and other middle and back ofﬁce services. Further information at www.hauck-aufhaeuser.de
IPConcept (Luxembourg) S.A.
Since the apo Medical Opportunities fund was launched in 2005, our partners have been IPConcept, which is the management company, and DZ PRIVATBANK S.A., which acts as the custodian bank as well as the payment, transfer and central administration office. Further information at www.ipconcept.lu and www.dz-privatbank.com
Deutsche Apotheker- und Ärztebank eG (Apobank) and apo Asset Management GmbH (apoAsset), Düsseldorf
Other long-term partners for the apo Medical Opportunities fund are the Apobank, which acts as the distribution agent, and apoAsset, which is second fund manager. Further information at www.apobank.de and www.apoasset.de
Apo Asset Management is taking a 25.1% stake in Medical Strategy. Medical Strategy remains independent as a company, both in terms of its investment philosophy and its management.